Literature DB >> 20123461

The psychology and neuropathology of phenylketonuria.

D A White1, S Waisbren, F J van Spronsen.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20123461     DOI： 10.1016/j.ymgme.2009.10.184

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN： 1096-7192            Impact factor:   4.797


× No keyword cloud information.
  5 in total

1.  A retrospective analysis of metabolic control in children with PKU in the COVID-19 era.

Authors:  Dóra Becsei; Erika Kiss; Ildikó Szatmári; András Arató; György Reusz; Attila J Szabó; János Bókay; Petra Zsidegh
Journal:  Mol Genet Metab Rep       Date:  2022-07-08

2.  Tract-based evaluation of white matter damage in individuals with early-treated phenylketonuria.

Authors:  Huiling Peng; Dawn Peck; Desirée A White; Shawn E Christ
Journal:  J Inherit Metab Dis       Date:  2013-09-17       Impact factor: 4.982

Review 3.  Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.

Authors:  Dominic J Gessler; Guangping Gao
Journal:  Methods Mol Biol       Date:  2016

4.  Pretreatment cognitive and neural differences between sapropterin dihydrochloride responders and non-responders with phenylketonuria.

Authors:  Zoë Hawks; Joshua Shimony; Jerrel Rutlin; Dorothy K Grange; Shawn E Christ; Desirée A White
Journal:  Mol Genet Metab Rep       Date:  2017-02-23

5.  Quality of life in children living with PKU - a single-center, cross-sectional, observational study from Hungary.

Authors:  Dóra Becsei; Réka Hiripi; Erika Kiss; Ildiko Szatmári; András Arató; György Reusz; Attila J Szabó; János Bókay; Petra Zsidegh
Journal:  Mol Genet Metab Rep       Date:  2021-11-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.